SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signaling

Table 1 Association between SLERT expression and clinicopathologic parameters

Parameters	All cases	SLERT expression		P value
Parameters	All cases	Low	High	P value
Age (years)
≤ 60	40	22	18	0.4
> 60	52	24	28	0.4
Histology type
Grade 1+2 endometrioid	67	36	31	0.31
Grade 3 endometrioid	24	10	14	0.31
FIGO stage
I–II	64	39	25	0.002
III–IV	28	7	21	0.002
Depth of invasion
≤ 50%	32	24	8	<0.001
> 50%	60	22	38	<0.001
Lymphovascular invasion
Negative	51	32	19	0.006
Positive	41	14	27	0.006
Lymph node metastasis
Negative	57	34	23	0.018
Positive	35	12	23	0.018

ISSN: 1477-7819